Low male partner attendance after syphilis screening in pregnant women leads to worse birth outcomes: the Syphilis Treatment of Partners (STOP) randomised control trial.
Journal
Sexual health
ISSN: 1449-8987
Titre abrégé: Sex Health
Pays: Australia
ID NLM: 101242667
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
28
05
2019
accepted:
09
10
2019
pubmed:
13
6
2020
medline:
31
8
2021
entrez:
13
6
2020
Statut:
ppublish
Résumé
Background Maternal syphilis causes poor birth outcomes, including congenital syphilis. Testing and treatment of partners prevents reinfection, but strategies to improve partner attendance are failing. The aim of this study was to determine the effectiveness of three partner notification strategies. Pregnant women with a positive point-of-care treponemal test at three antenatal clinics (ANCs) in Kampala, Uganda, were randomised 1:1:1 to receive either notification slips (NS; standard of care), NS and a text messages (SMS) or NS and telephone calls. The primary outcome was the proportion of partners who attended the ANC and were treated for syphilis. Between 2015 and 2016, 17130 pregnant women were screened; 601 (3.5%) had a positive treponemal result, and 442 were enrolled in the study. Only 81 of 442 partners (18.3%; 23/152 (15.1%), 31/144 (21.5%) and 27/146 (18.5%) in the NS only, NS + SMS and NS + telephone call groups respectively) attended an ANC for follow-up; there were no significant differences between the groups. Twelve per cent of women attended the ANC with their male partner, and this proportion increased over time. Partner non-treatment was independently associated with adverse birth outcomes (odds ratio 2.75; 95% confidence interval 2.36-3.21; P < 0.001). Only 18.3% of partners of pregnant women who tested positive for syphilis received treatment. Female partners of non-attendant men had worse birth outcomes. Encouraging men to accompany women to the ANC and testing both may address the urgent need to treat partners of pregnant women in sub-Saharan Africa to reduce poor fetal outcomes.
Identifiants
pubmed: 32527365
pii: SH19092
doi: 10.1071/SH19092
pmc: PMC7974021
mid: NIHMS1675297
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
214-222Subventions
Organisme : NIBIB NIH HHS
ID : U54 EB007958
Pays : United States
Références
Cochrane Database Syst Rev. 2013 Oct 03;(10):CD002843
pubmed: 24092529
J Health Commun. 2015;20(10):1224-9
pubmed: 26042660
BMC Infect Dis. 2015 Jan 13;15:15
pubmed: 25583097
Sex Transm Dis. 1996 Jul-Aug;23(4):289-92
pubmed: 8836022
Genitourin Med. 1996 Aug;72(4):247-52
pubmed: 8976827
Health Technol Assess. 2014 Jan;18(2):1-100, vii-viii
pubmed: 24411488
Soc Sci Med. 2001 Nov;53(10):1287-301
pubmed: 11676401
Lancet Glob Health. 2016 Aug;4(8):e525-33
pubmed: 27443780
Sex Transm Dis. 2015 Sep;42(9):533-9
pubmed: 26267881
J Infect Dis. 2002 Oct 1;186(7):940-7
pubmed: 12232834
J Health Commun. 2016 Jun;21(6):629-37
pubmed: 27144318
PLoS Med. 2013 Nov;10(11):e1001545
pubmed: 24223524
J Infect Dis. 2002 Oct 1;186(7):948-57
pubmed: 12232835
Sex Transm Dis. 2010 Sep;37(9):563-5
pubmed: 20351621
Patient Prefer Adherence. 2017 Aug 31;11:1479-1487
pubmed: 28919720
BMC Public Health. 2010 Jan 18;10:19
pubmed: 20082718
Int J Gynaecol Obstet. 2015 Jun;130 Suppl 1:S15-21
pubmed: 26001704
Lancet. 2003 Feb 22;361(9358):645-52
pubmed: 12606175
Bull World Health Organ. 2013 Mar 1;91(3):217-26
pubmed: 23476094
Genitourin Med. 1996 Feb;72(1):56-9
pubmed: 8655169
Sex Transm Dis. 1997 Oct;24(9):511-8
pubmed: 9339968
AIDS Behav. 2018 Oct;22(10):3407-3416
pubmed: 29372453
Sex Transm Dis. 1995 Jul-Aug;22(4):231-5
pubmed: 7482106
Sex Transm Infect. 1998 Dec;74(6):409-14
pubmed: 10195049
BMC Infect Dis. 2019 Feb 6;19(1):124
pubmed: 30727950